Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0V6MX
|
|||
Drug Name |
IMA 203
|
|||
Drug Type |
Cell therapy
|
|||
Indication | Hematologic tumour [ICD-11: 2B33.Y] | Phase 1 | [1] | |
Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C00-D48; ICD-9: 140-199] | Phase 1 | [1] | ||
Company |
Immatics
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Tumor expressed melanoma antigen (PRAME) | Target Info | . | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | Clinical pipeline report, company report or official report of Immatics. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.